Kornélia Tacsi

Kornélia Tacsi

Auto-generated profile, based on publicly available information

Kornélia Tacsi

Department of Organic Chemistry and Technology, Faculty of Chemical Technology and Biotechnology, Budapest University of Technology and Economics, Műegyetem rkp. 3, Budapest 1111, Hungary

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 May 2020 in Crystal Growth & Design
Verified
Journal Article
Closed access
KTKornélia Tacsi
Kornélia Tacsi
HPHajnalka Pataki
Hajnalka Pataki
ADAndrás Domokos
András Domokos
BNBrigitta Nagy
Brigitta Nagy
ICIstván Csontos
István Csontos
GMGyörgy Marosi
György Marosi

29 December 2021 in Organic Process Research & Development
Verified
Journal Article
Open access
ADAndrás Domokos
András Domokos
LMLajos Madarász
Lajos Madarász
GSGyörgy Stoffán
György Stoffán
KTKornélia Tacsi
Kornélia Tacsi
DGDorián Galata
Dorián Galata
HPHajnalka Pataki
Hajnalka Pataki
In this work, we developed an in-line image analysis system for the monitoring of the continuous crystallization of an active pharmaceutical ingredient. Acetylsalicylic acid was crystallized in a mixed suspension mixed product removal crystallizer, which was equipped with overflow tubing as an outlet. A steep glass plate was placed under the outlet onto which the slurry dripped on its surface. The glass plate spread and guided the droplets toward the product collection filter. A high-speed process camera was mounted above the glass plate to capture images of the crystals. Several light sources were tested in various positions to find the appropriate experimental setup for the optimal image quality. Samples were taken during continuous operation for off-line particle size analysis in order to compare to the crystal size distributions calculated from the images. The results were in good agreement, and the trends of the process could be followed well using the images. As a next step, image analysis was operated throughout the entire continuous crystallization experiment, and a huge quantity of information was collected from the process. The crystal size distribution of the product was calculated every 30 s, which provided a thorough and detailed insight into the crystallization process.

17 February 2023 in International Journal of Pharmaceutics
Verified
Journal Article
Open access
KTKornélia Tacsi
Kornélia Tacsi
GSGyörgy Stoffán
György Stoffán
DGDorián László Galata
Dorián László Galata
ÉPÉva Pusztai
Éva Pusztai
MGMartin Gyürkés
Martin Gyürkés
HPHajnalka Pataki
Hajnalka Pataki
Continuous crystallization in the presence of polymer additives is a promising method to omit some drug formulation steps by improving the technological and also pharmacological properties of crystalline active ingredients. Accordingly, this study focuses on developing an additive-assisted continuous crystallization process using polyvinylpyrrolidone in a connected ultrasonicated plug flow crystallizer and an overflow mixed suspension mixed product removal (MSMPR) crystallizer system. We aimed to improve the flowability characteristics of small, columnar primary plug flow crystallizer-produced acetylsalicylic acid crystals as a model drug by promoting their agglomeration in MSMPR crystallizer with polyvinylpyrrolidone. The impact of the cooling antisolvent crystallization process parameters (temperature, polymer amount, total flow rate) on product quality and quantity was investigated. Finally, a spatially segmented antisolvent dosing method was also evaluated. The developed technology enabled the manufacture of purified, constant quality products in a short startup period, even with an 85% yield. We found that a higher polymer amount (7.5-14%) could facilitate agglomeration resulting in "good" flowability without altering the favorable dissolution characteristics of the primary particles.

19 September 2024 in International Journal of Pharmaceutics
Verified
Journal Article
Open access
KTKornélia Tacsi
Kornélia Tacsi
DGDorián László Galata
Dorián László Galata
ADAndrás Domokos
András Domokos
ÉPÉva Pusztai
Éva Pusztai
BNBrigitta Nagy
Brigitta Nagy
HPHajnalka Pataki
Hajnalka Pataki
In the pharmaceutical industry, filtration is traditionally carried out in batch mode. However, with the spread of continuous technologies, there is an increasing demand for robust continuous filtration strategies suitable for processing suspensions produced in continuous crystallizers. Accordingly, this study aimed to investigate a lab- scale horizontal conveyor belt filtration approach for pharmaceutical separation purposes for the first time. The newly developed continuous horizontal belt filter (CHBF) was tested under different systems (microcrystalline cellulose (MCC)/water, lactose/ethanol and acetylsalicylic acid (ASA)/water) and diverse conditions. Filtration was robust using a well-defined unimodal particle size distribution MCC in water system, where the residual moisture content varied within narrow limits of 45-52% independently from the process conditions. Besides, the residual moisture content highly depended on the applied solvent and particle size. It could be reduced to below 2% by processing the suspensions of either a volatile solvent (lactose in ethanol) or an aqueous slurry of a large particle size ASA. Finally, the CHBF was connected to a mixed suspension mixed product removal (MSMPR) or a plug flow crystallizer (PFC). The residual moisture content of the CHBF-filtered ASA product and operation characteristics (onset of steady-state) were evaluated in both continuous crystallizer-filter systems. The MSMPRCHBF system operated with a longer startup period. The size of the in situ-produced crystals was of a similar order magnitude in both systems, resulting in a similar residual moisture content (around 20%). Overall, the tested continuous filter was robust, did not modify the crystal morphology in the examined experimental range, and could be effectively integrated with continuous crystallizers.

24 July 2025 in International Journal of Pharmaceutics
Verified
Journal Article
Open access
GSGyörgy Nimród Stoffán
György Nimród Stoffán
THTibor Höltzl
Tibor Höltzl
ZLZsolt Lőrincz
Zsolt Lőrincz
ÉPÉva Pusztai
Éva Pusztai
KTKornélia Tacsi
Kornélia Tacsi
HPHajnalka Pataki
Hajnalka Pataki
Utilizing the positive impact of additives, including pharmaceutical excipients, to achieve favorable crystal morphology and polymorphism is a widely researched area. Despite the obvious benefits of additive-assisted crystallization, the quantification of process parameter influences on the effect mechanism of additives is usually discussed only from a nucleation inhibition point of view or focusing on technological feasibility. Accordingly, the relevant literature can be divided into technological and mechanism studies, but it lacks a complex combined approach. However, to develop robust crystallization procedures, the systematic analysis of process conditions is essential. Thus, understanding the molecular-scale effect mechanism is also crucial to designing these complex processes. Therefore, in this work, the effect of a pharmaceutical binder, poly(vinyl pyrrolidone) (PVP), and several process parameters were investigated on the nucleation of famotidine (FMT), an antihistamine, both experimentally and theoretically. To systematically investigate the effect of PVP concentration, temperature, and supersaturation, we applied the Design of Experiment (DoE) methodology combined with a camera-aided analytical set-up. Based on the experimental data, the nucleation rate of FMT was studied according to the Classical Nucleation Theory (CNT). Finally, molecular simulations were conducted, and a possible effect mechanism was suggested for the PVP-effected nucleation of FMT. This way, the complex DoE-based process parameter investigation and molecular scale interpretation of these effects is a novel approach of the subject. The experimental results revealed that the nucleation inhibiting effect of PVP is dependent on the set temperature, while increasing FMT concentration generally counterforces it. Based on the CNT calculations, PVP decreased the nucleation rate of FMT by orders of magnitude. Additionally, molecular modelling suggests the effect mechanism of PVP is manifested through H-bonding and steric hindrance.

1 January 2023
Verified
Conference Paper
Closed access
GSGyörgy Nimród Stoffán
György Nimród Stoffán
ZLZsolt Lőrincz
Zsolt Lőrincz
KSKornélia Szabó-Tacsi
Kornélia Szabó-Tacsi
GMGyörgy Marosi
György Marosi
HPHajnalka Pataki
Hajnalka Pataki